However, differences in the duration of diabetes were observed among new users of GLP-1 RAs; approximately 20% of patients had <1 year of history of diabetes in all sites except in Quebec and in the UK, where <3% had a diabetes duration of <1 year. The gene discussed is GLP1R; the disease is diabetes mellitus.